Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Introducing Risk Stratification Reduces Patient Burden and Improves Cost-Effectiveness of Hepatocellular Carcinoma Surveillance for People with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Modelling Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Same author

The Prevalence and Risk Factors for at-Risk MASH and Advanced Liver Fibrosis in People With Metabolic Risk Factors in Primary Care.

Alimentary pharmacology & therapeutics·2026

Same author

Noninvasive Prediction of Decompensation in Compensated Advanced Chronic Liver Disease and a Liver Stiffness From 15 to 25 kPa.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Same author

A Supervised, Online, Home-Based Eccentric Resistance Exercise Program for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastroenterology research·2026

Same author

Haemochromatosis - a modern clinician's guide.

Internal medicine journal·2026

Same author

Metabolic dysfunction-associated fatty liver disease: an update.

Australian prescriber·2026

Search research articles

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

Texture-based classification of liver fibrosis using MRI.

Michael J House¹, Sander J Bangma, Mervyn Thomas

¹School of Physics, The University of Western Australia, Crawley, Western Australia, Australia.

Journal of Magnetic Resonance Imaging : JMRI

|December 19, 2013

Summary

MRI texture analysis shows promise for staging liver fibrosis, particularly for excluding severe cases. Combining MRI measures with clinical data improves diagnostic accuracy for liver fibrosis staging.

Keywords:

MRI classification liver fibrosis texture analysis

More Related Videos

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

Area of Science:

Medical Imaging
Hepatology
Radiology

Background:

Liver fibrosis staging is crucial for patient management.
Current noninvasive methods for fibrosis staging have limitations.
Liver biopsy remains the gold standard but is invasive.

Purpose of the Study:

To evaluate the efficacy of MRI texture analysis in staging liver fibrosis.
To determine if MRI texture analysis can serve as a noninvasive alternative to biopsy.
To assess the diagnostic performance of texture features in differentiating fibrosis stages.

Main Methods:

Forty-nine patients with biopsy-confirmed liver fibrosis were included.
T2-weighted, high-resolution spin echo MRI sequences were acquired.
Haralick texture features were extracted and analyzed using AUROC.

Main Results:

The best mean AUROC for distinguishing mild from severe fibrosis was 0.81.
Incorporating age, liver fat, and R2 values improved AUROC to 0.91 for F0 vs. F1-4.
Texture analysis showed modest performance in classifying mild and intermediate fibrosis stages.

Conclusions:

MRI texture analysis, combined with clinical factors, may help exclude liver fibrosis.
This approach shows potential as a noninvasive tool for liver fibrosis assessment.
Further refinement is needed for accurate staging of mild to intermediate fibrosis.